Success Metrics

Clinical Success Rate
87.2%

Based on 655 completed trials

Completion Rate
87%(655/751)
Active Trials
111(10%)
Results Posted
38%(247 trials)
Terminated
96(8%)

Phase Distribution

Ph phase_4
291
25%
Ph phase_2
189
16%
Ph phase_1
173
15%
Ph phase_3
115
10%
Ph early_phase_1
39
3%
Ph not_applicable
336
29%

Phase Distribution

212

Early Stage

189

Mid Stage

406

Late Stage

Phase Distribution1143 total trials
Early Phase 1First-in-human
39(3.4%)
Phase 1Safety & dosage
173(15.1%)
Phase 2Efficacy & side effects
189(16.5%)
Phase 3Large-scale testing
115(10.1%)
Phase 4Post-market surveillance
291(25.5%)
N/ANon-phased studies
336(29.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.6%

655 of 813 finished

Non-Completion Rate

19.4%

158 ended early

Currently Active

111

trials recruiting

Total Trials

1,146

all time

Status Distribution
Active(151)
Completed(655)
Terminated(158)
Other(182)

Detailed Status

Completed655
unknown176
Terminated96
Recruiting86
Withdrawn62
Not yet recruiting32

Development Timeline

Analytics

Development Status

Total Trials
1146
Active
111
Success Rate
87.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 139 (3.4%)
Phase 1173 (15.1%)
Phase 2189 (16.5%)
Phase 3115 (10.1%)
Phase 4291 (25.5%)
N/A336 (29.4%)

Trials by Status

recruiting868%
unknown17615%
active_not_recruiting252%
not_yet_recruiting323%
completed65557%
suspended61%
enrolling_by_invitation81%
terminated968%
withdrawn625%

Recent Activity

Clinical Trials (1,146)

Showing 20 of 1,146 trialsScroll for more
NCT05898087Phase 4

Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty

Completed
NCT02134925Phase 2

Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps

Active Not Recruiting
NCT07703514Phase 1

Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates

Not Yet Recruiting
NCT07217899Phase 2

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

Recruiting
NCT01843504Phase 2

Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy

Completed
NCT06963112Phase 1

Intraoperative Midazolam on Delirium Outcome of Elderly Patients

Completed
NCT06634030Phase 2

Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction

Completed
NCT02392442Phase 2

Effects of Bronchial Segmental Endotoxin Instillation in Humans

Enrolling By Invitation
NCT04763343Phase 3

Ketamine Treatment of Youth Suicide Attempters

Recruiting
NCT07168915Phase 1

A Study of V118E in Healthy Participants (V118E-003)

Recruiting
NCT05169229Phase 2

Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.

Recruiting
NCT03446456Phase 1

Vasopressin and Pain Perception in the Brain

Recruiting
NCT07655804Phase 3

Subcutaneous Calcitonin in Acute Herpes Zoster

Recruiting
NCT07487246Phase 2

Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement

Recruiting
NCT07131033Phase 1

Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholecystectomy

Completed
NCT06857955Phase 2

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

Active Not Recruiting
NCT06480201Phase 1

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

Recruiting
NCT04018859Phase 2

Platelet-rich Plasma for Eyebrows

Active Not Recruiting
NCT04260854Phase 1

Bupivacaine Hydrochloride for Pain Control in Cutaneous Surgery

Enrolling By Invitation
NCT05952804Phase 2

IVIG for Infection Prevention After CAR-T-Cell Therapy

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
1,146